Malcisbo Ltd.

📍 Switzerland👥 5 employees💰 Last funded 2011
Biotechnology Research🌐 malcisbo.com
Website LinkedIn
Sweet vaccines are novel carbohydrate based vaccines being developed by the company Malcisbo. The first targets are unmet medical needs such as Campylobacter induced food poisoning and parasitic infections by the blood sucking stomach worm Hemonchus in sheep causing losses in food production. Malcisbo has developed a proprietary target discovery platform which it will use in combination with glycoengineering technologies to provide novel and efficient glycoconjugate vaccines. The discovery platform will generate a constant outflow of novel vaccines for unmet human and veterinary medical needs. Further projects are affordable vaccines to protect people in underdeveloped areas against parasitic worm infections.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Malcisbo Ltd.?
Malcisbo Ltd. has 1 investors on record on gritt.io.
When did Malcisbo Ltd. last raise funding?
The most recent investment in Malcisbo Ltd. recorded on gritt.io was in 2011.
What industry is Malcisbo Ltd. in?
Malcisbo Ltd. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Malcisbo Ltd. based?
Malcisbo Ltd. is headquartered in Switzerland.